North America Catastrophic Antiphospholipid Syndrome Market Size & Outlook
The catastrophic antiphospholipid syndrome market in North America is expected to reach a projected revenue of US$ 3,524.5 million by 2030. A compound annual growth rate of 10.6% is expected of North America catastrophic antiphospholipid syndrome market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,745.4
Forecast, 2030 (US$M)
$3,524.5
CAGR, 2024 - 2030
10.6%
Report Coverage
North America
North America catastrophic antiphospholipid syndrome market, 2018-2030 (US$M)
Related Markets
North America catastrophic antiphospholipid syndrome market highlights
- The North America catastrophic antiphospholipid syndrome market generated a revenue of USD 1,745.4 million in 2023.
- The market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, anticoagulants was the largest revenue generating treatment in 2023.
- Anticoagulants is the most lucrative treatment segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 1,745.4 million |
| Market revenue in 2030 | USD 3,524.5 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Anticoagulants |
| Fastest growing segment | Anticoagulants |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticoagulants |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Bristol-Myers Squibb Co, Eli Lilly and Co, Boehringer Ingelheim, Novartis AG ADR, Merck KGaA, AbbVie Inc, Roche Holding AG, Johnson & Johnson |
Other key industry trends
- In terms of revenue, North America region accounted for 39.5% of the global catastrophic antiphospholipid syndrome market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,220.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Catastrophic Antiphospholipid Syndrome Market Scope
Catastrophic antiphospholipid syndrome market segmentation & scope
Immunosuppressive Therapy
Plasma Exchange Therapy (Plasmapheresis)
Intravenous Immunoglobulin (IVIG)
Other Treatment
End Use
Hospitals
Specialty Clinics
Others
Countries
U.S.
Canada
Mexico
UK
Sweden
Spain
Norway
Italy
Germany
Denmark
France
Australia
China
India
Japan
Thailand
South Korea
Saudi Arabia
South Africa
UAE
Kuwait
Argentina
Brazil
Catastrophic Antiphospholipid Syndrome Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America catastrophic antiphospholipid syndrome market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
